Pedro Blecua Carrillo Albornoz

3PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer cell biologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 23, 2021
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma.

Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles

|Jun 12, 2020
The DNA methylation landscape of hematological malignancies: an update.

Pedro Blecua, Laura Martinez-Verbo, Manel Esteller

Pageof 1